Study Group: High Pressure Liquid Chromatography Users (US)

Council Members in this Study Group: 38

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Stan Schofield, Vice President, MAINEHEALTHStan Schofield

Vice President
MAINEHEALTH
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Stan Schofield is the President of NorDx, a regional laboratory corporation within the Maine Health System. He also serves as Vice President and Senior Member of the Health System Executive Management Team. Mr. Schofield is the Founder and Managing Principal...

B. Michael Silber, Chief of Drug Discovery R&D and Professor, University of California, San Francisco - CCB. Michael Silber

Chief of Drug Discovery R&D and Professor
University of California, San Francisco - CC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Michael Silber, PhD, is Professor of Neurology, Bioengineering and Therapeutic Sciences, and Chief of Drug Discovery R & D, at the Institute for Neurodegenerative Diseases, UCSF School of Medicine. He has 25 years of experience as a senior leader in Pharma...

Diab Elmashni

Global DIrector of Marketing Communications
THERMO FISHER SCIENTIFIC INC.
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Diab Elmashni, MBA, is a Global Director of Marketing Communications at Thermo Fisher Scientific, since January 2001. There, he is responsible for strategy and delivery of global marketing communications for a 650 million dollar liquid chromatography...

Join this Study Group

Members in this Study Group include these company types:

  • Pharmaceuticals Manufacturer
  • Academic Medical Center/Hospital or Clinic
  • Biotechnology Manufacturer
  • Academic Institution*
  • Pharmaceuticals/Biotechnology Research Services
  • Lab, Academic Medical Center

Members in this Study Group often have these job titles:

  • Research Scientist
  • Director
  • President
  • Chemist
  • Chief Executive Officer
  • Researcher

Related Study Groups

Study Group Name No. Members
Pricing Experts on Clinical Lab Testing in the U.S. 58
Economic Experts on Managed Care 804
Medical Device Experts 513
Users of APTIMA Combo 2 for Testing Chlamydia and Gonorrhea (US) 19
Cosmetics Experts 662
Ventana Symphony Users 14
FullTerm Fibronectin (fFN) Test Users (US) 44
Users of BRACAnalysis Testing for Breast and Ovarian Cancer (US) 131